Revenue and EPS growth for FY26 were in line with objectives, driven by strong 3DEXPERIENCE and Cloud adoption, and expansion in Life Sciences through the ArisGlobal acquisition. ARR grew 6% year-over-year, operating margin improved, and free cash flow rose 13%.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.